There are multiple reports describing the MARCKS protein being associated with invasion in glioblastoma, cholangiocarcinoma, leukemia, melanoma, ovarian cancer, prostate cancer, and inflammatory breast cancer (21, 45–51). This evidence concerns the gene MARCKS and prostate cancer.